RSNA 2025 – Imaging the Individual
The 25th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, WCO-IOF-ESCEO 2025 will be held in Rome, Italy between 10-13 April 2025.
WCO-IOF-ESCEO 2025
The 25th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, WCO-IOF-ESCEO 2025 will be held in Rome, Italy between 10-13 April 2025.
REMS Performance
A recent study titled “Proposed practice parameters for the performance of radiofrequency Echographic multispectrometry (REMS) evaluations” was published on the Bone Joint Open by international key Opinion Leaders from the USA and UK.
REMS vs DXA
Does Radiofrequency Echographic Multi-Spectrometry (REMS) perform similarly to Dual-energy X-ray Absorptiometry (DXA) in terms of Trabecular Bone Score (TBS) and FRAX? Débora […]
HTA Study in USA
Radiofrequency Echographic Multi-Spectrometry (REMS) is an innovative, non-ionizing diagnostic technique that has shown high accuracy and precision, making it a promising alternative to DXA for osteoporosis diagnosis in clinical settings.
ARAB HEALTH 2025
Echolight at the ARAB HEALTH TRADE SHOW. Echolight SpA is proud to invite you to the Arab Health Trade Show taking place […]
Echolight Announces Multi-Year Agreement with Siemens Healthineers
HOUSTON, Nov. 18, 2024 /PRNewswire/ — Echolight, a global innovator in bone densitometry, announced that it has signed an agreement enabling Siemens Healthineers to […]
Echolight & NASA
NASA NOW EQUIPPED WITH ECHOLIGHT DEVICES FOR BONE HEALTH MONITORING IN SPACEFLIGHT SIMULATIONS HOUSTON, Oct. 21, 2024 /PRNewswire/ — Echolight, a global […]
REMS & Motor disability
“Radiofrequency echographic multi-spectrometry-based measurement of bone mineral density in patients with severe motor and intellectual disability: An opportunity for patients with severe […]
